Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial

Abroad (travel likely)RecruitingPHASE4

Conditions

Lupus Nephritis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • AARA Clinical Research, Glendale, Arizona, United States

    Contact: Study coordinator (Cody Price) · Garth.Price@aaracr.com · 602-386-4970
    Contact: Principal Investigator (Eric Peters, MD)
  • Piedmont Physicians Rheumatology, Atlanta, Georgia, United States

    Contact: Study coordinator (Kimberly Pruitt) · kimberly.pruitt@piedmont.org · 404-367-3350
    Contact: Principal Investigator (Wambui Machua, MD)
  • Georgia Nephrology Research Institute, Lawrenceville, Georgia, United States

    Contact: Study coordinator (Jeremy Whitson, CCRA, CCRP) · jwhitson@ganephrology.com · 423-943-4264
    Contact: Study coordinator (Terry Smith) · tsmith@nephronet.com · 423-967-0917
    Contact: Principal Investigator (James A Tumlin, MD)
  • Parris & Associates, Lawrenceville, Georgia, United States

    Contact: Study coordinator (Mannai Coutermarsh) · m.coutermarsh@parrisandassociates.net · 678-471-6289
    Contact: Principal Investigator (Glen Parris, MD)
  • Nephrology Clinical Trials Unit The Ohio State University Wexner Medical Center, Columbus, Ohio, United States

    Contact: Study coordinator (Laci Roberts) · laci.roberts@osumc.edu · 614-685-5323
    Contact: Principal Investigator (Isabelle Ayoub, MD)
  • Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, United States

    Contact: Study coordinator (Kallena Haynes) · Kallena-haynes@omrf.org · 405-271-3046
    Contact: Principal Investigator (Christina Arriens, MD)
  • AARA Clinical Research, Fort Worth, Texas, United States

    Contact: Study coordinator (Lainne Carey) · Lainne.Carey@aaracr.com · 214-276-6560
    Contact: Principal Investigator (Shariq Chudhri, DO)
Study leads
  • James Tumlin, MD

    Principal Investigator

    NephroNet, Inc.